Analysts' Actions -- Altera, Nike, Oracle, Madison Square Garden and More
NEW YORK (TheStreet) -- RATINGS CHANGES
Altera (ALTR) - Get Report was downgraded at Morgan Stanley to equal-weight. Valuation call, based on a 12-month price target of $44, Morgan Stanley said.
Broadcom (BRCM) was upgraded at Nomura to buy. Twelve-month price target is $50. Stock has pulled back to an attractive level and the company is a potential takeover target, Nomura said.
ConAgra Foods (CAG) - Get Report was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: CAG Ratings Report.
Madison Square Garden (MSG) - Get Report was upgraded to buy from hold at Topeka Capital. Twelve-month price target is $97. Business split should unlock value, Topeka Capital said.
Madison Square Garden was upgraded at Morgan Stanley to overweight. Twelve-month price target is $94. Restructuring plan should help unlock shareholder value, Morgan Stanley said.
Nike
(NKE) - Get Report
was upgraded at Robert Baird to outperform from neutral. Valuation call, as the company can deliver consistent 15% annual earnings growth, Robert Baird said.
Oracle (ORCL) - Get Report was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $50. Company can show better cloud growth and improvement in the database business, RBC Capital said.
Potash Corp. of Saskatchewan (POT) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: POT Ratings Report.
Restoration Hardware (RH) - Get Report was upgraded at Goldman Sachs to buy. Twelve-month price target is $114. Company can deliver above-average square footage growth and continue to leverage its online business, Goldman Sachs said.
Xilinx (XLNX) - Get Report was downgraded at MKM Partners to neutral from buy. Twelve-month price target is $45. Valuation call, as the company could face increased competition if Intel (INTC) - Get Report acquires Altera, MKM Partners said.
Xilinx was downgraded at Morgan Stanley to equal-weight from overweight. Twelve-month price target is $44. Company would face increased competition if Intel buys Altera, Morgan Stanley said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.
Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.